Humacyte, Inc. Increase (Decrease) in Other Employee-Related Liabilities
Humacyte, Inc. (HUMA) reported Increase (Decrease) in Other Employee-Related Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities · last filed 2024-03-28
- Humacyte, Inc. increase (decrease) in other employee-related liabilities for fiscal 2023 was $0.00.
- Humacyte, Inc. increase (decrease) in other employee-related liabilities for fiscal 2022 was -$173.00K.
- Humacyte, Inc. increase (decrease) in other employee-related liabilities for fiscal 2021 was -$116.00K, a 140.14% decline from fiscal 2020.
- Humacyte, Inc. increase (decrease) in other employee-related liabilities for fiscal 2020 was $289.00K.
| Period end | Increase (Decrease) in Other Employee-Related Liabilities 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-12-31 | -$173.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | -$116.00K 10-K · filed 2023-03-24 |
| 2020-12-31 | $289.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |